Corcept Therapeutics Inc. (CORT), which posted strong financial results for the third quarter yesterday, is anticipating a ...
Sabrina Gomes, 24, has seen her skin get progressively darker since having a surgical procedure two years ago, but has had to fight in court to get the expensive treatment that could reverse it ...
Actor and comedian Amy Schumer said she was diagnosed with Cushing’s syndrome, a relatively rare hormonal disorder that can ...
Cushing's syndrome is a debilitating disorder which requires rapid reversal of hypercortisolemia to limit morbidity. The primary treatment for Cushing's syndrome remains surgical although residual ...
People with the rare disease Cushing’s syndrome can sometimes take years to get a diagnosis, but a new project hopes to shorten that timeline with the help of artificial intelligence.
THIS report describes a patient with Cushing's syndrome who presented two unusual manifestations. In the first place, it is generally accepted that one of the cardinal features of Cushing's ...
In addition, Sparrow announced that clofutriben has been granted Orphan Drug Designation by the US Food and Drug Administration (FDA) for the treatment of endogenous Cushing’s syndrome.
Actress and director Amy Schumer has revealed she has Cushing's Syndrome, caused by having steroid injections in high doses. She revealed the condition after being swarmed by comments about her ...
A hormone associated with stress, cortisol, can significantly influence not only your health but also your appearance.
Salivary cortisol measurements are particularly useful to investigate cyclical Cushing's syndrome. At least partial autonomy of cortisol production (either direct from the adrenal cortex or ...
While we believe the first three and the 6th are the most important (*), items #4 and #5 could provide important further evidence of the much greater prevalence of Cushing's Syndrome and what we ...
Virbac has launched Trilotab, the first chewable, flavoured and divisible trilostane tablet to treat Cushing’s syndrome in ...